On October 1, 2025, Dyne Therapeutics, Inc. appointed Brian Posner as an independent director, granting him options for 70,000 shares at $12.50 each and an annual cash compensation of $45,000. This follows the Board's recommendation and he will serve until the 2026 Annual Meeting.